MAHINDRA MANULIFE LARGE CAP FUND
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
Note: Mahindra Manulife Large Cap Pragati Yojana scheme has been renamed as Mahindra Manulife Large Cap Fund w.e.f. March 1, 2023.

Data as on 28th, February 2023

Investment Objective The investment objective of the Scheme is to provide long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in large cap companies. However, there can be no assurance that the investment objective of the Scheme will be achieved.
Fund Features Agile quality portfolio from India’s Big 100 Companies*
Exposure to the more stable half of the market
High conviction bottom up stock picking with a focus on alpha generation
*In terms of Full Market Capitalisation.
Fund Manager and Experience Fund Manager: Mr. Abhinav Khandelwal
Total Experience:14 years
Experience in managing this fund: 1 Year (Managing since March 1, 2022)
Fund Manager: Ms. Fatema Pacha
Total Experience: 17 years
Experience in managing this fund: 2 years and 2 Month(Managing since December 21, 2020)
Date of allotment March 15, 2019
Benchmark Nifty 100 Index TRI
Options IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D) D-Default
Application Amount Rs. 1,000 and in multiples of Re. 1/- thereafter
Additional Purchase Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter
SIP Minimum Weekly & Monthly SIP Amount: Rs 500 and in multiples of Re 1 thereafter
Minimum Weekly & Monthly SIP Installments: 6
Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re 1 thereafter
Minimum Quarterly SIP installments: 4
Minimum Amount for Switch in: Rs. 1,000/- and in multiples of Re. 0.01/- thereafter.
Minimum Amount for Redemption / Switch-outs: Rs. 1,000/- or 100 units or account balance, whichever is lower in respect of each Option.
Monthly AAUM as on February 28, 2023 (Rs. in Cr.): 220.27
Monthly AUM as on February 28, 2023 (Rs. in Cr.): 215.81
Total Expense Ratio1 as on
February 28, 2023:
Regular Plan: 2.67%
Direct Plan:0.67%
1Includes additional expenses charged in terms of Regulation 52(6A)(b) and 52(6A)(c) of SEBI (Mutual Funds) Regulations, 1996 and Goods and Service Tax.
Load Structure: Entry Load: N.A.
Exit Load: An Exit Load of 1% is payable if Units are redeemed / switched-out upto 1 year from the date of allotment
Nil if Units are redeemed / switched-out after 1 year from the date of allotment

Portfolio Turnover Ratio (Last 1 year): 1.11
Standard Deviation: 20.29%
Beta: 0.88
Sharpe Ratio#: 0.46
Jenson’s Alpha : -0.0377
#Risk-free rate assumed to be 6.70% (MIBOR as on 28-02-23) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns for last 3 years. Data as on February 28, 2023

NAV as on February 28, 2023
NAV/Unit
Regular Plan (In Rs.)
Direct Plan (In Rs.)
IDCW
12.6480
13.7964
Growth
15.1199
16.3004
IDCW: Income Distribution cum Capital Withdrawal

Issuer
% of Net Assets
Automobile and Auto Components
6.89%
Maruti Suzuki India Limited
3.86%
Tata Motors Limited
2.04%
Samvardhana Motherson International Limited
1.00%
Capital Goods
3.17%
Bharat Electronics Limited
1.36%
Tega Industries Limited
1.06%
Grindwell Norton Limited
0.75%
Construction
4.18%
Larsen & Toubro Limited
4.18%
Construction Materials
3.23%
UltraTech Cement Limited
1.68%
Grasim Industries Limited
1.54%
Consumer Durables
0.61%
Titan Company Limited
0.61%
Fast Moving Consumer Goods
8.71%
Hindustan Unilever Limited
2.98%
United Spirits Limited
2.10%
Dabur India Limited
2.00%
Balrampur Chini Mills Limited
1.11%
Britannia Industries Limited
0.52%
Financial Services
35.07%
HDFC Bank Limited
9.53%
ICICI Bank Limited
9.17%
State Bank of India
4.17%
Axis Bank Limited
3.97%
HDFC Life Insurance Company Limited
2.24%
IndusInd Bank Limited
2.09%
Bajaj Finance Limited
1.96%
Housing Development Finance Corporation Limited
1.94%
Healthcare
4.89%
Torrent Pharmaceuticals Limited
1.49%
Sun Pharmaceutical Industries Limited
1.49%
Apollo Hospitals Enterprise Limited
1.02%
Abbott India Limited
0.89%
Information Technology
15.83%
Infosys Limited
7.04%
Tata Consultancy Services Limited
5.92%
LTIMindtree Limited
1.45%
Wipro Limited
1.44%
Metals & Mining
1.28%
Hindalco Industries Limited
1.28%
Oil Gas & Consumable Fuels
8.86%
Reliance Industries Limited
7.34%
GAIL (India) Limited
1.52%
Power
1.95%
NTPC Limited
1.95%
Realty
1.49%
DLF Limited
1.49%
Services
0.55%
Container Corporation of India Limited
0.55%
Telecommunication
2.34%
Bharti Airtel Limited
2.34%
Equity and Equity Related Total
99.05%
Cash & Other Receivables
0.95%
Grand Total
100.00%
( Top Ten Holdings - Issuer wise) as on February 28, 2023)

Mahindra Manulife Large Cap Fund
CAGR Returns (%)
Value of Investment of Rs. 10,000*
NAV / Index Value
(as on
February 28, 2023)
Managed by Mr. Abhinav Khandelwal & Ms. Fatema Pacha
1 Year
3 Years
Since Inception
1 Year
3 Years
Since Inception
Regular Plan - Growth Option
0.89
14.82
11.00
10,089
15,143
15,120
15.1199
Direct Plan - Growth Option
2.88
16.95
13.13
10,288
16,004
16,300
16.3004
Nifty 100 Index TRI^
1.56
16.03
11.56
10,156
15,627
15,422
22,766.58
S&P BSE Sensex TRI^^
6.19
16.86
13.02
10,619
15,966
16,242
89,281.77

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular and Direct Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Abhinav Khandelwal is managing this scheme since March 1, 2022. Ms. Fatema Pacha is managing this scheme since December 21, 2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. For performance details of other schemes managed by the Fund Manager(s), please click here | Best Viewed in Landscape mode

Mahindra Manulife Large Cap Fund
Regular Plan
Direct Plan
Nifty 100 Index TRI^
S&P BSE Sensex TRI^^
SIP Investment Period
Total Amount Invested ()
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
1 Year
120,000
118,075
-2.99
119,369
-0.98
117,593
-3.73
122,506
3.93
3 Years
360,000
427,563
11.53
441,602
13.78
432,711
12.36
448,456
14.85
5 Years
NA
NA
NA
NA
NA
NA
NA
NA
NA
Since Inception
470,000
589,099
11.57
614,072
13.75
598,735
12.42
620,661
14.31

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 15-Mar-2019. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return). For SIP Performance please click here | Best Viewed in Landscape mode

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

As per the latest Market Capitalisation data provided by AMFI (In line with the applicable SEBI guidelines)

Record Date
Plan(s) / Option(s)
IDCW
Face Value
Cum-IDCW NAV
(Rs. per unit)
(Rs. per unit)
(Rs. per unit)
17-Sep-21
Regular IDCW
0.50
10
15.5063
17-Sep-21
Direct IDCW
0.50
10
16.2534
17-Mar-22
Regular IDCW
1.00
10
14.2722
17-Mar-22
Direct IDCW
1.00
10
15.1213
27-Feb-23
Regular IDCW
1.00
10
14.0070
27-Feb-23
Direct IDCW
1.00
10
15.1798

Pursuant to payment of IDCW, the NAV of the IDCW Option(s) of the Scheme/Plan(s) falls to the extent of payout and statutory levy, if any. Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. For complete list of IDCWs, visit www.mahindramanulife.com.

Product Suitability
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Scheme Riskometers
Benchmark Riskometers

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA
Scheme Benchmark: Nifty 100  Index TRI
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.